Ikarian Capital, LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 1778253 DALLAS, TX

Back to RVMD Full portfolio

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,865,559

+$4,862,549 QoQ

Shares Held

163,142

+18.1% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

2.57%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$9,238,750

PutShares

95,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	328,635	$43,793,900
2	KOD	Kodiak Sciences Inc.	1,059,730	$41,287,080
3	ALMS	Alumis Inc.	870,548	$24,497,220
4	PRAX	Praxis Precision Medicines, Inc.	72,842	$24,386,773
5	PCVX	Vaxcyte, Inc.	388,682	$22,594,084
6	CLDX	Celldex Therapeutics, Inc.	478,500	$17,804,985
7	RCUS	Arcus Biosciences, Inc.	504,559	$15,555,553
8	RLMD	Relmada Therapeutics, Inc.	2,148,359	$14,866,644

All Filings in RVMD

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,238,750	95,000	+4568.3%	Put	Sole	2026-05-15
2026-03-31	$15,865,559	163,142	+18.1%	Shares	Sole	2026-05-15
2025-12-31	$7,566,750	95,000	0.0%	Call	Sole	2026-02-18
2025-12-31	$11,003,010	138,142	—	Shares	Sole	2026-02-18
2025-09-30	$4,436,500	95,000	-36.7%	Call	Sole	2025-11-14
2023-09-30	$56,328	2,035	—	Put	Sole	2023-11-14
2021-03-31	$6,882,000	150,000	—	Call	Sole	2021-08-18
No filing history on record for this holder in this stock.